Clinical Trial Update: Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the clinical benefit and safety of raxibacumab in patients with symptomatic inhalational anthrax in a mass exposure scenario; sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inhalational Anthrax

Drugs mentioned

• Raxibacumab (raxibacumab)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Infections, Bacterial | Phase 4 | Status: NOT_YET_RECRUITING